Role of RND Efflux Pumps in Drug Resistance of Cystic Fibrosis Pathogens.

Autor: Scoffone VC; Department of Biology and Biotechnology 'Lazzaro Spallanzani', University of Pavia, 27100 Pavia, Italy., Trespidi G; Department of Biology and Biotechnology 'Lazzaro Spallanzani', University of Pavia, 27100 Pavia, Italy., Barbieri G; Department of Biology and Biotechnology 'Lazzaro Spallanzani', University of Pavia, 27100 Pavia, Italy., Irudal S; Department of Biology and Biotechnology 'Lazzaro Spallanzani', University of Pavia, 27100 Pavia, Italy., Perrin E; Department of Biology, University of Florence, 50019 Sesto Fiorentino, Italy., Buroni S; Department of Biology and Biotechnology 'Lazzaro Spallanzani', University of Pavia, 27100 Pavia, Italy.
Jazyk: angličtina
Zdroj: Antibiotics (Basel, Switzerland) [Antibiotics (Basel)] 2021 Jul 15; Vol. 10 (7). Date of Electronic Publication: 2021 Jul 15.
DOI: 10.3390/antibiotics10070863
Abstrakt: Drug resistance represents a great concern among people with cystic fibrosis (CF), due to the recurrent and prolonged antibiotic therapy they should often undergo. Among Multi Drug Resistance (MDR) determinants, Resistance-Nodulation-cell Division (RND) efflux pumps have been reported as the main contributors, due to their ability to extrude a wide variety of molecules out of the bacterial cell. In this review, we summarize the principal RND efflux pump families described in CF pathogens, focusing on the main Gram-negative bacterial species ( Pseudomonas aeruginosa , Burkholderia cenocepacia , Achromobacter xylosoxidans , Stenotrophomonas maltophilia ) for which a predominant role of RND pumps has been associated to MDR phenotypes.
Databáze: MEDLINE